30 June 2026
Latham & Watkins Advises Remix Therapeutics in Merger With Passage Bio
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Leah Sauter Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Gloria Ring Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Elisabeth Martin Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Kyle Adams | Latham & Watkins LLP | Associate | corporate | Not stated |
| Noah Ruzi | Latham & Watkins LLP | Associate | corporate | Not stated |
| Michael Pioso | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jessica Kerr | Latham & Watkins LLP | Associate | corporate | Not stated |
| Elizabeth Gemdjian | Latham & Watkins LLP | Associate | corporate | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | FDA and regulatory matters | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA and regulatory matters | Not stated |
| Matthew Conway | Latham & Watkins LLP | Partner | executive compensation, employment, and benefits matters | Not stated |
| Bryce Groce | Latham & Watkins LLP | Associate | executive compensation, employment, and benefits matters | Not stated |
| Christine Mainguy | Latham & Watkins LLP | Partner | tax matters | Not stated |
| Katharine Moir | Latham & Watkins LLP | Partner | tax matters | Not stated |
| Tessa Young | Latham & Watkins LLP | Associate | tax matters | Not stated |
| Steven Chinowsky | Latham & Watkins LLP | Partner | intellectual property matters | Not stated |
| Arun Mohan | Latham & Watkins LLP | Associate | intellectual property matters | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | intellectual property matters | Not stated |
16 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Remix Therapeutics, Inc.Target
- Counterparties
- Passage Bio, Inc. (Buy-side)